Skip to Content
Merck
  • Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice.

Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice.

Neuron (2003-04-30)
Raul R Gainetdinov, Laura M Bohn, Tatyana D Sotnikova, Michel Cyr, Aki Laakso, Alexander D Macrae, Gonzalo E Torres, Kyeong Man Kim, Robert J Lefkowitz, Marc G Caron, Richard T Premont
ABSTRACT

Brain dopaminergic transmission is a critical component in numerous vital functions, and its dysfunction is involved in several disorders, including addiction and Parkinson's disease. Responses to dopamine are mediated via G protein-coupled dopamine receptors (D1-D5). Desensitization of G protein-coupled receptors is mediated via phosphorylation by members of the family of G protein-coupled receptor kinases (GRK1-GRK7). Here we show that GRK6-deficient mice are supersensitive to the locomotor-stimulating effect of psychostimulants, including cocaine and amphetamine. In addition, these mice demonstrate an enhanced coupling of striatal D2-like dopamine receptors to G proteins and augmented locomotor response to direct dopamine agonists both in intact and in dopamine-depleted animals. The present study indicates that postsynaptic D2-like dopamine receptors are physiological targets for GRK6 and suggests that this regulatory mechanism contributes to central dopaminergic supersensitivity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
GRK6, active, GST tagged human, PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution